Join Mintz for the next installment in our COVID-19 webinar series for life sciences companies. This session will explore the widespread disruptions the crisis is posing to clinical trials for life sciences companies and to research study sites. We will also discuss recent guidance from regulatory authorities and practical steps for both sponsors and researchers to address emerging issues.

The program will cover the following topics:

• Regulatory authority accommodations for ongoing clinical trials that may be affected by COVID-19 and regional restrictions

• Overview of the current clinical trials landscape during the COVID-19 pandemic

• Key considerations for sponsors and study sites regarding ongoing and planned clinical trials

• Considerations for companies interested in commencing a clinical trial for a COVID-19 product candidate